Acute hepatitis associated with montelukast [2]

Journal of Hepatology

Volumn 38, Issue 5, 2003, Pages 694-695

  Russmann, Stefan ^a   Iselin, Hans U ^b   Meier, Dominik ^b   Zimmermann, Arthur ^a   Simon, Hans Uwe ^a   Caduff, Pia ^c   Reichen, Jürg ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Department of Internal Medicine   (Switzerland)

^c Swiss Agy for Therapeutic Products   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST; SABAL EXTRACT; SERETINE; ZAFIRLUKAST;

ACUTE HEPATITIS; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLERGIC ASTHMA; AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT OBSTRUCTION; BILIRUBIN BLOOD LEVEL; CASE REPORT; CELL PROLIFERATION; CONCENTRATION RESPONSE; DATA BASE; DISEASE ASSOCIATION; DISEASE COURSE; ECHOGRAPHY; FATIGUE; HISTOLOGY; HUMAN; HYDROXYLATION; IN VITRO STUDY; JAUNDICE; LATENT PERIOD; LETTER; LIVER INJURY; LIVER TOXICITY; LYMPHOCYTE TRANSFORMATION; LYMPHOCYTE TRANSFORMATION TEST; MALE; PRIORITY JOURNAL; PROPHYLAXIS; SEROLOGY; STIMULATION; VALIDATION PROCESS; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 0037879077     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00085-0     Document Type: Letter

References (8)

1. Actis GC, Morgando A, Lagget M, David E, Rizzetto M. Zafirlukast-related hepatitis: report of a further case. J Hepatol 2001;35:539-541.
2. Danese S, De Vitis I, Gasbarrini A. Severe liver injury associated with zafirlukast. Ann Intern Med 2001;135:930.
3. Moles JR. Primo J, Fernandez JM, Hinojosa JE. Acute hepatocellular injury associated with zafirlukast. J Hepatol 2001;35:541-542.
4. Reinus JF, Persky S, Burkiewicz JS, Quan D, Bass NM, Davern TJ. Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast. Ann Intern Med 2000;133:964-968.
5. Sass DA, Chopra KB, Wu T. A case of montelukast-induced cholestatic jaundice. Am J Gastroenterol 2002;97(Suppl):S222.
6. Maria VA, Victorino RM. Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury. Gut 1997;41:534-540.
7. Chiba M, Xu X, Nishime JA, Balani SK, Lin JH. Hepatic microsomal metabolism of montelukast, a potent leukotriene D4 receptor antagonist, in humans. Drug Metab Dispos 1997;25:1022-1031.
8. WHO. Online search for organ class 0700 (gastrointestinal and hepatic system) and montelukast, zafirlukast and serenoa repens. Uppsala Monitoring Centre: 2002.